DUBLIN--(BUSINESS WIRE)--The "Global Auto-Injectors Market Size, Share, Development, Growth and Demand Forecast to 2023" report has been added to Research and Markets' offering.
The global auto-injectors market is expected to witness a CAGR of 18.6% during the forecast period (2017 - 2023). Rising prevalence of anaphylaxis and increasing healthcare spending are some of the key drivers for the global market growth.
Additionally, emerging biologic drug therapies, minimized needle-stick injuries and growing aging population also support the growth of the global market.
On the other hand, the auto-injectors market has been facing certain challenges such as high cost of auto-injectors, leading to low adherence and stringent regulatory requirements, which may impede its growth during the forecast period.
The increasing demand and penetration of auto-injectors in emerging economies offers enormous growth opportunities for the global auto-injectors market. With high economic growth and increasing government initiatives in Asia-Pacific, the major auto-injectors manufacturers are penetrating into the untapped market in the region.
Needle-stick injury during drug administration can lead to blood-borne pathogen transmission, therefore healthcare workers can experience anxiety, fear and emotional distress. This risk associated with the use of the needle-stick is reduced by using auto-injectors. According to World Health Organization (WHO), approximately 16 billion injections are administered every year, globally; however, most of the syringes and needles are not properly disposed.
Key Topics Covered:
1. Research Background
2. Research Methodology
3. Executive Summary
5. Market Size And Forecast By Product
6. Market Size And Forecast By Manufacturing Design
7. Market Size And Forecast By Therapeutic Application
8. Market Size And Forecast By Geography
9. Competitive Landscape
10. Company Profiles
- Mylan N.V.
- Antares Pharma Inc.
- Becton, Dickinson And Company
- Eli Lilly And Company
- Pfizer Inc.
- Bayer Ag
- Bristol- Myer Squibb
- Novartis Ag
- Amgen Inc.
For more information about this report visit https://www.researchandmarkets.com/research/mrbvx8/global